Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Timothy P Clackson. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Timothy P Clackson har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ELEV / Elevation Oncology, Inc. | Director | 0 |
US: / THESEUS PHARMACEUTICALS INC | President and CEO, Director | 351 030 |
US:FMTX / Forma Therapeutics Holdings Inc | Director | 0 |
US:XLO / Xilio Therapeutics, Inc. | 10% Owner | 20 068 |
US:849CVR014 / CVR F STAR | Director | 50 486 |
US:ARIA / ARIAD Pharmaceuticals, Inc. | President, R&D, CSO | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Timothy P Clackson. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp XLO / Xilio Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i XLO / Xilio Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i XLO / Xilio Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Timothy P Clackson som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-24 |
|
4 | ELEV |
Elevation Oncology, Inc.
Common Stock |
U - Other | −47 330 | 0 | −100,00 | 0,36 | −17 039 | ||
2023-09-05 |
|
4 | ELEV |
Elevation Oncology, Inc.
Common Stock |
G - Gift | −15 777 | 0 | −100,00 | ||||
2022-11-14 |
|
4 | THRX |
Theseus Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 2 500 | 351 030 | 0,72 | 6,80 | 16 995 | 2 386 302 | |
2022-10-14 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
U - Other | −7 250 | 0 | −100,00 | ||||
2022-10-14 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
U - Other | −23 590 | 0 | −100,00 | ||||
2022-06-22 |
|
4 | ELEV |
Elevation Oncology, Inc.
Common Stock |
G - Gift | −31 553 | 15 777 | −66,67 | ||||
2022-06-09 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
A - Award | 4 500 | 30 840 | 17,08 | ||||
2022-02-23 |
|
4 | THRX |
Theseus Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 450 000 | 450 000 | |||||
2021-12-22 |
|
4 | THRX |
Theseus Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 2 600 | 348 530 | 0,75 | 9,76 | 25 381 | 3 402 385 | |
2021-10-21 | 3 | XLO |
Xilio Therapeutics, Inc.
Common Stock |
20 068 | ||||||||
2021-10-21 | 3 | XLO |
Xilio Therapeutics, Inc.
Common Stock |
70 888 | ||||||||
2021-10-06 | 3 | THRX |
Theseus Pharmaceuticals, Inc.
Common Stock |
345 930 | ||||||||
2021-06-24 | 3 | ELEV |
Elevation Oncology, Inc.
Common Stock |
47 330 | ||||||||
2021-06-21 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy) |
A - Award | 8 375 | 8 375 | |||||
2021-06-21 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
A - Award | 2 750 | 26 340 | 11,66 | ||||
2020-10-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 9 422 | 50 486 | 22,94 | ||||
2020-07-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 588 | 41 064 | 26,44 | ||||
2020-06-25 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2020-06-24 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
S - Sale | −35 067 | 0 | −100,00 | ||||
2020-06-24 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.,
Common Stock |
P - Purchase | 23 590 | 23 590 | |||||
2020-06-22 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy) |
A - Award | 17 533 | 0 | −100,00 | ||||
2020-06-18 | 3 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
43 144 | ||||||||
2020-06-18 | 3 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
43 144 | ||||||||
2020-06-18 | 3 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
43 144 | ||||||||
2020-04-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 13 575 | 32 476 | 71,82 | ||||
2020-01-02 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 7 991 | 18 901 | 73,24 | ||||
2019-10-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 3 670 | 10 910 | 50,69 | ||||
2019-07-11 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2019-07-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 3 421 | 7 240 | 89,58 | ||||
2019-04-02 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 204 | 3 819 | 46,04 | ||||
2019-01-03 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 083 | 2 615 | 70,69 | ||||
2018-10-02 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 788 | 1 532 | 105,91 | ||||
2018-07-03 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 744 | 744 | |||||
2018-03-05 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2018-03-05 | 3 | SBPH |
Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned |
0 | ||||||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −14 550 | 0 | −100,00 | ||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −72 980 | 0 | −100,00 | ||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −87 125 | 0 | −100,00 | ||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −65 000 | 0 | −100,00 | ||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −82 000 | 0 | −100,00 | ||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −577 | 0 | −100,00 | ||||
2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −219 867 | 0 | −100,00 | ||||
2017-02-07 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 14 550 | 14 550 | |||||
2017-02-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −29 333 | 0 | −100,00 | ||||
2017-02-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | −9 610 | 219 867 | −4,19 | 23,82 | −228 886 | 5 236 682 | |
2017-02-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 333 | 229 477 | 14,66 | ||||
2016-10-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −19 638 | 197 884 | −9,03 | 9,56 | −187 739 | 1 891 771 |
2016-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 750 | 217 522 | −3,87 | 13,98 | −122 311 | 3 040 610 |
2016-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | −17 500 | 0 | −100,00 | ||||
2016-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 500 | 226 272 | 8,38 | ||||
2016-09-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 208 772 | −8,74 | 13,43 | −268 536 | 2 803 140 |
2016-09-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −59 369 | 0 | −100,00 | ||||
2016-09-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −59 369 | 228 772 | −20,60 | 11,73 | −696 398 | 2 683 496 |
2016-09-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 59 369 | 288 141 | 25,95 | 7,82 | 464 266 | 2 253 263 |
2016-08-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −19 436 | 228 772 | −7,83 | 10,47 | −203 538 | 2 395 746 |
2016-08-15 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2016-08-15 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −25 000 | 248 208 | −9,15 | 10,50 | −262 500 | 2 606 184 |
2016-08-15 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 000 | 273 208 | 10,07 | 7,69 | 192 250 | 2 100 970 |
2016-07-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 286 | 248 208 | −6,86 | 8,11 | −148 230 | 2 012 024 |
2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −30 000 | 0 | −100,00 | 3,25 | −97 500 | ||
2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −31 422 | 0 | −100,00 | 4,49 | −141 085 | ||
2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 266 494 | −10,12 | 7,48 | −224 481 | 1 994 095 |
2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 296 494 | 11,26 | 3,25 | 97 500 | 963 606 |
2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −31 422 | 266 494 | −10,55 | 7,48 | −235 153 | 1 994 361 |
2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 31 422 | 297 916 | 11,79 | 4,49 | 141 085 | 1 337 643 |
2016-06-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 999 | 264 742 | −8,31 | 7,28 | −174 638 | 1 926 501 |
2016-05-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −17 762 | 288 741 | −5,80 | 8,08 | −143 430 | 2 331 612 |
2016-05-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 700 | 306 503 | −3,68 | 7,13 | −83 478 | 2 186 868 |
2016-05-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −23 400 | 0 | −100,00 | ||||
2016-05-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 400 | 318 203 | 7,94 | ||||
2016-04-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 409 | 294 803 | −6,77 | 7,37 | −157 864 | 2 173 789 |
2016-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 834 | 316 212 | −7,01 | 6,58 | −156 871 | 2 081 244 |
2016-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −10 833 | 0 | −100,00 | ||||
2016-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 417 | 340 046 | −1,57 | 6,47 | −35 039 | 2 199 520 |
2016-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 833 | 345 463 | 3,24 | ||||
2016-03-09 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 26 180 | 26 180 | |||||
2016-03-09 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
A - Award | 87 125 | 87 125 | |||||
2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 625 | 334 630 | −2,80 | 6,12 | −58 867 | 2 046 631 |
2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | −25 047 | 344 255 | −6,78 | 6,00 | −150 282 | 2 065 530 | |
2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
A - Award | 38 500 | 38 500 | |||||
2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | −19 250 | 19 250 | −50,00 | ||||
2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 250 | 369 302 | 5,50 | ||||
2016-02-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −29 333 | 29 333 | −50,00 | ||||
2016-02-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 667 | 350 052 | −4,02 | 4,81 | −70 517 | 1 683 015 |
2016-02-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 333 | 364 719 | 8,75 | ||||
2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 750 | 334 086 | −2,55 | 6,46 | −56 560 | 2 159 532 |
2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
A - Award | 35 000 | 35 000 | |||||
2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | −17 500 | 17 500 | −50,00 | ||||
2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 500 | 342 836 | 5,38 | ||||
2015-07-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 000 | 325 336 | −2,11 | 8,54 | −59 797 | 2 779 150 |
2015-07-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | −14 000 | 0 | −100,00 | ||||
2015-07-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 000 | 332 336 | 4,40 | ||||
2015-04-30 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 70 200 | 70 200 | |||||
2015-04-27 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −123 766 | 316 548 | −28,11 | 9,50 | −1 175 777 | 3 007 206 |
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −13 333 | 0 | −100,00 | ||||
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 667 | 440 314 | −1,49 | 8,55 | −57 016 | 3 765 565 |
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 333 | 446 981 | 3,07 | ||||
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 417 | 433 648 | −1,23 | 8,84 | −47 910 | 3 835 313 |
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 657 | 0 | −100,00 | ||||
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −10 833 | 10 833 | −50,00 | ||||
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | −20 657 | 440 314 | −4,48 | 9,00 | −185 913 | 3 962 826 | |
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 20 657 | 460 971 | 4,69 | 7,56 | 156 167 | 3 484 941 | |
2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 833 | 439 065 | 2,53 | ||||
2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −24 036 | 31 422 | −43,34 | ||||
2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −24 999 | 0 | −100,00 | ||||
2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −24 036 | 428 232 | −5,31 | 8,00 | −192 288 | 3 425 856 |
2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 24 036 | 452 268 | 5,61 | 4,49 | 107 922 | 2 030 683 | |
2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −24 999 | 428 232 | −5,52 | 8,00 | −199 992 | 3 425 856 |
2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 24 999 | 453 231 | 5,84 | 2,62 | 65 497 | 1 187 465 | |
2015-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −29 334 | 58 666 | −33,33 | ||||
2015-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 667 | 428 232 | −3,31 | 6,33 | −92 820 | 2 710 066 |
2015-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 334 | 442 899 | 7,09 | ||||
2014-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | −14 000 | 14 000 | −50,00 | ||||
2014-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | −4 564 | 413 565 | −1,09 | 5,57 | −25 421 | 2 303 557 | |
2014-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 000 | 418 129 | 3,46 | ||||
2014-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 500 | 403 028 | −1,59 | 8,21 | −53 337 | 3 307 127 |
2014-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −13 000 | 0 | −100,00 | ||||
2014-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 000 | 409 528 | 3,28 | ||||
2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 667 | 394 377 | −1,66 | 7,89 | −52 583 | 3 110 451 |
2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −13 333 | 13 333 | −50,00 | ||||
2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 333 | 401 044 | 3,44 | ||||
2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −10 834 | 21 666 | −33,34 | ||||
2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | −3 442 | 387 711 | −0,88 | 8,19 | −28 190 | 3 175 353 | |
2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 834 | 391 153 | 2,85 | ||||
2014-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 88 000 | 88 000 | |||||
2013-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 750 | 380 319 | −2,50 | 5,14 | −50 115 | 1 954 840 |
2013-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 500 | 390 069 | 5,26 | ||||
2013-09-10 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 449 | 370 451 | −2,23 | 22,00 | −185 878 | 8 149 922 |
2013-07-18 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 000 | 378 900 | −3,56 | 19,79 | −277 045 | 7 498 014 |
2013-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | −28 000 | 28 000 | −50,00 | ||||
2013-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
A - Award | 56 000 | 56 000 | |||||
2013-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 28 000 | 392 900 | 7,67 | ||||
2013-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 500 | 363 705 | −1,76 | 18,04 | −117 245 | 6 560 402 | |
2013-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −13 000 | 0 | −100,00 | ||||
2013-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 000 | 370 205 | 3,64 | ||||
2013-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | −19 167 | 357 205 | −5,09 | 18,87 | −361 766 | 6 742 030 | |
2013-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −38 333 | 0 | −100,00 | ||||
2013-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 38 333 | 376 372 | 11,34 | ||||
2013-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 667 | 338 039 | −1,93 | 19,46 | −129 718 | 6 577 123 | |
2013-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −13 334 | 0 | −100,00 | ||||
2013-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 334 | 344 706 | 4,02 | ||||
2013-03-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
A - Award | 65 000 | 65 000 | |||||
2013-03-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 32 500 | 32 500 | |||||
2013-03-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 838 | 331 372 | −2,88 | 21,00 | −206 598 | 6 958 812 |
2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −8 631 | 17 262 | −33,33 | ||||
2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −44 542 | 0 | −100,00 | ||||
2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −4 766 | 0 | −100,00 | ||||
2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 631 | 341 210 | 2,60 | 7,82 | 67 494 | 2 668 262 | |
2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 44 542 | 332 579 | 15,46 | 4,49 | 199 994 | 1 493 280 | |
2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 766 | 288 037 | 1,68 | 5,23 | 24 926 | 1 506 434 | |
2012-12-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −27 000 | 4 766 | −85,00 | ||||
2012-12-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 27 000 | 282 940 | 10,55 | 5,23 | 141 210 | 1 479 776 | |
2012-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | −8 142 | 255 940 | −3,08 | 20,18 | −164 306 | 5 164 869 | |
2012-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 500 | 264 082 | 7,97 | ||||
2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −1 | 24 999 | 0,00 | ||||
2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −10 000 | 30 000 | −25,00 | ||||
2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 | 244 170 | 0,00 | 2,62 | 3 | 639 725 | |
2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 244 169 | 4,27 | 3,25 | 32 500 | 793 549 | |
2012-08-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −36 843 | 0 | −100,00 | ||||
2012-08-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −36 843 | 234 169 | −13,59 | 20,00 | −736 860 | 4 683 380 |
2012-08-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 36 843 | 271 012 | 15,73 | 7,56 | 278 533 | 2 048 851 | |
2012-08-01 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −23 234 | 31 766 | −42,24 | ||||
2012-08-01 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 234 | 234 169 | −9,03 | 19,00 | −441 446 | 4 449 211 |
2012-08-01 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 234 | 257 403 | 9,92 | 5,23 | 121 514 | 1 346 218 | |
2012-05-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2012-05-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 233 778 | −7,88 | 17,00 | −340 000 | 3 974 226 |
2012-05-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 20 000 | 253 778 | 8,56 | 7,44 | 148 800 | 1 888 108 | |
2012-04-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 111 | 233 778 | −2,95 | 15,00 | −106 665 | 3 506 670 |
2012-04-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −31 600 | 240 889 | −11,60 | 14,83 | −468 628 | 3 572 384 |
2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 200 | 272 489 | −1,87 | 16,18 | −84 134 | 4 408 763 |
2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −13 000 | 26 000 | −33,33 | ||||
2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 000 | 277 689 | 4,91 | ||||
2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −26 061 | 264 689 | −8,96 | 16,34 | −425 876 | 4 325 415 |
2012-03-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2012-03-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 500 | 290 750 | −2,51 | 16,00 | −120 000 | 4 652 000 |
2012-03-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 500 | 298 250 | 2,58 | 6,39 | 47 925 | 1 905 818 | |
2012-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 333 | 290 750 | −5,01 | 15,41 | −236 211 | 4 479 120 |
2012-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −38 333 | 38 333 | −50,00 | ||||
2012-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 38 333 | 306 083 | 14,32 | ||||
2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 40 000 | 40 000 | |||||
2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
A - Award | 82 000 | 82 000 | |||||
2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | −36 400 | 267 750 | −11,97 | 15,02 | −546 622 | 4 020 829 | |
2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | 91 000 | 0 | −100,00 | ||||
2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | −91 000 | 304 150 | −23,03 | ||||
2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −8 449 | 0 | −100,00 | ||||
2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −6 615 | 0 | −100,00 | ||||
2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 449 | 213 150 | 4,13 | 4,19 | 35 401 | 893 098 | |
2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 615 | 204 701 | 3,34 | 4,05 | 26 791 | 829 039 | |
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −16 500 | 16 500 | −50,00 | ||||
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −41 551 | 8 449 | −83,10 | ||||
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −18 385 | 6 615 | −73,54 | ||||
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −76 436 | 119 882 | −38,93 | 15,12 | −1 155 781 | 1 812 724 |
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 500 | 196 318 | 9,18 | 3,90 | 64 350 | 765 640 | |
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 41 551 | 179 818 | 30,05 | 4,19 | 174 099 | 753 437 | |
2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 385 | 138 267 | 15,34 | 4,05 | 74 459 | 559 981 |